TCRX

Tscan Therapeutics, Inc.

• TipRanks·09/11 13:00

  TScan Therapeutics Launches Executive Retention Incentive Program

• Dow Jones·09/08 15:25

  TScan Therapeutics Price Target Cut to $1.00/Share From $7.00 by HC Wainwright & Co.

• Dow Jones·09/08 15:25

  TScan Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

• TipRanks·09/08 12:40

  TScan Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

• NASDAQ·09/04 14:09

  Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals

• Dow Jones·09/03 13:19

  TScan Therapeutics Price Target Cut to $1.00/Share From $5.00 by Wedbush

• Dow Jones·09/03 13:19

  TScan Therapeutics Cut to Neutral From Outperform by Wedbush

• Dow Jones·09/03 09:16

  TScan Therapeutics Cut to Hold From Buy by Needham

• TipRanks·09/02 20:05

  TScan downgraded to Market Perform from Outperform at LifeSci Capital

• TipRanks·09/02 20:00

  Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and TScan Therapeutics (TCRX)

• TipRanks·09/02 18:05

  Needham downgrades TScan Therapeutics as company reprioritizes

• TipRanks·09/02 17:50

  TScan Therapeutics downgraded to Hold from Buy at Needham

• TipRanks·09/02 14:25

  TScan Therapeutics downgraded to Neutral from Outperform at Wedbush

• NASDAQ·09/02 13:03

  TScan Therapeutics Reorganizes To Focus On Solid Tumor Program; To Cut 75% Jobs; Stock Tumbles 11%

• TipRanks·09/02 11:59

  TScan Therapeutics Restructures to Focus on Solid Tumors